Encodia

Developer of a highly-parallelized protein analysis platform intended to study proteomes easily

Description

Developer of a highly-parallelized protein analysis platform intended to study proteomes easily. The company's platform provides scalable and parallelized proteins, enabling researchers to study proteomics, proteins and peptides.

Company Status

The company raised an estimated $4 million of Series B venture funding from Nan Fung Life Sciences on July 20, 2018, putting the company's pre-money valuation at $100 million.

Primary Industry Sector / Group / Code

Verticals

Service Providers

Services on a Deal
Name	Type
Gunderson Dettmer	Legal Advisor

Keywords

peptides analysis, protein analysis, protein analysis tools, proteomics diagnostic, proteomics technology

General Information

Company Former Name

ProCure Life Sciences
All Industries

Biotechnology*, Other Pharmaceuticals and Biotechnology
Company Financing Status

Venture Capital-Backed
Total Raised

$34.00M
Business Status

Generating Revenue
Ownership Status

Privately Held (backing)
Universe

Venture Capital
Website

http://www.encodia.com
Year Founded

2015

Investors

Active Investors
	ARCH Venture Partners
	Biomatics Capital
	Nan Fung Life Sciences
	National Institutes of Health
	U.S. Department of Health and Human Services

Acquirers

First Financing

First Financing Size

$10.00M
First Financing Size Status

Estimated
First Financing Valuation

$25.00M
First Financing Valuation Status

Estimated
First Financing Deal Type

Early Stage VC
First Financing Deal Type 2

Series A
First Financing Deal Class

Venture Capital
First Financing Status

Completed

Last Financing

Last Financing Date

July 20, 2018
Last Financing Size

$4.00M
Last Financing Size Status

Estimated
Last Financing Valuation

$104.00M
Last Financing Valuation Status

Actual
Last Financing Deal Type

Early Stage VC
Last Financing Deal Type 2

Series B
Last Financing Deal Class

Venture Capital
Last Financing Status

Completed

Location

Get Directions

Primary Contact

Primary Contact

Kevin Gunderson
Primary Contact Title

Co-Founder, Vice President & Chief Technology Officer
Primary Contact Email

kgunderson@encodiabio.com
Primary Contact Phone

+1 (858) 345-6272

Headquarters

HQ Location

11125 Flintkote Ave, San Diego, CA 92121, USA
HQ Address Line 1

11125 Flintkote Avenue
HQ Address Line 2

Suite B
HQ City

San Diego
HQ State/Province

California
HQ Post Code

92121
HQ Country

United States
HQ Phone

+1 (858) 345-6272
HQ Email

info@encodia.com
HQ Global Region

Americas
HQ Global Sub Region

North America

No comments yet.